Literature DB >> 19103566

Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.

Sajjan Aryal1, Natasa Skalko-Basnet.   

Abstract

Multi-drug tablets of amlodipine besylate and atenolol were prepared as either mono-layer (mixed matrix) or bilayer tablets containing each drug in a separate layer by using similar excipients and processing. Each tablet batch was packed in strip and blister packs and kept under accelerated temperature and humidity conditions. The stability of two tablet and packaging types was compared by HPLC analysis after 0, 1, 3 and 4.5 months and expressed as the content of intact amlodipine and atenolol. The content of atenolol did not decline regardless of tablet and packaging type. Amlodipine content in bi-layer tablets decreased to about 95 and 88% when packed in strips and blisters, respectively. When prepared as mono-layer tablets, the content decreased to 72 and 32%, respectively.The study revealed that the bi-layer tablet formulation was more stable than the mono-layer type. Further, the stability was increased when the tablets were packed in aluminium strips as compared to PVC blisters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103566     DOI: 10.2478/v10007-008-0012-5

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  4 in total

1.  Factors to consider in developing individual pharmaceutical product quality risk profiles useful to government procurement agencies.

Authors:  Wei Xu; Garth Boehm; Qiang Zheng
Journal:  Acta Pharm Sin B       Date:  2015-12-17       Impact factor: 11.413

2.  Investigating the physical stability of repackaged medicines stored into commercially available multicompartment compliance aids (MCAs).

Authors:  Bahijja Tolulope Raimi-Abraham; Alba Garcia Del Valle; Carlota Varon Galcera; Susan Anne Barker; Mine Orlu
Journal:  J Pharm Health Serv Res       Date:  2017-05-08

3.  Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate.

Authors:  Hong-Goo Lee; Yun-Sang Park; Jin-Hyuk Jeong; Yong-Bin Kwon; Dae Hwan Shin; Ju-Young Kim; Yun-Seok Rhee; Eun-Seok Park; Dong-Wook Kim; Chun-Woong Park
Journal:  Drug Des Devel Ther       Date:  2019-07-23       Impact factor: 4.162

Review 4.  Formulations of Amlodipine: A Review.

Authors:  Muhammad Ali Sheraz; Syed Furqan Ahsan; Marium Fatima Khan; Sofia Ahmed; Iqbal Ahmad
Journal:  J Pharm (Cairo)       Date:  2016-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.